Collegium Pharmaceutical (COLL) Free Cash Flow (2017 - 2026)
Collegium Pharmaceutical (COLL) free cash flow from Sep 30, 2017 to Mar 31, 2026. The TTM Collegium Pharmaceutical (COLL) free cash flow is $330M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Collegium Pharmaceutical (COLL) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +67.80% |
| 3 Years TTM | +23.40% |
| 5 Years TTM | +23.23% |
| All Time TTM | +14.01% |
Annual Free Cash Flow change of Collegium Pharmaceutical (COLL)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $57M | -82.65% |
| 2025 | $328M | +61.11% |
| 2024 | $203M | -25.87% |
| 2023 | $274M | +123.71% |
| 2022 | $123M | +20.66% |
| 2021 | $102M | +14.97% |
| 2020 | $88M | +314.20% |
| 2019 | $21M | -86.98% |
| 2018 | $164M | -341.01% |
| 2017 | -$68M | N/A |
Comparison Collegium Pharmaceutical (COLL) five years free cash flow CAGR with competitors
Collegium Pharmaceutical (COLL) five years free cash flow CAGR is 23.23%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| LNTH | Lantheus Holdings Inc | 89.22% | +284.01% |
| SBFM | Sunshine Biopharma Inc | 88.60% | +281.34% |
| ORGO | Organogenesis Holdings Inc - Class A | 87.05% | +274.66% |
| HROW | Harrow Inc | 51.26% | +120.63% |
| ANIP | ANI Pharmaceuticals Inc | 45.89% | +97.49% |
| ALKS | Alkermes plc | 36.06% | +55.21% |
| PCRX | Pacira BioSciences Inc | 27.91% | +20.13% |
| NBIX | Neurocrine Biosciences Inc | 25.83% | +11.18% |
| AMPH | Amphastar Pharmaceuticals Inc | 24.53% | +5.56% |
| ALVO | Alvotech | 21.39% | -7.92% |
| UTHR | United Therapeutics Corp | 12.12% | -47.85% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.21% | -56.04% |
| PAHC | Phibro Animal Health Corp - Class A | 6.13% | -73.61% |
| ZTS | Zoetis Inc - Class A | 4.90% | -78.93% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -87.41% |
| EOLS | Evolus Inc | 0.82% | -96.45% |
| BHC | Bausch Health Companies Inc | 0.61% | -97.36% |